Australia’s Acrux Gets Favorable Results From Spray-On Contraceptive
This article was originally published in PharmAsia News
Executive Summary
Australian drug maker Acrux has Nestorone (progestin) in trial that could be the first spray-on contraceptive drug. Acrux is seeking commercial partners for the drug after it showed favorable results in trials. The drug, a fourth-generation progestin, is sprayed onto the skin with a small, hand-held device that allows delivery in smaller doses than usual to reduce side-effects. Nestorone is applied daily to the forearm where it passes through the skin into the bloodstream, reducing the amount of progestin needed in oral doses. (Click here for more